High insulin and leptin increase resistin and inflammatory cytokine production from human mononuclear cells

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Tsiotra, Panayoula C ^a   Boutati, Eleni ^b   Dimitriadis, George ^b   Raptis, Sotirios A ^a,b  

^a Prevention and Treatment of Diabetes Mellitus and Its Complications   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEXAMETHASONE; GLUCOSE; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; MESSENGER RNA; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; AUTACOID; RETN PROTEIN, HUMAN; SWEETENING AGENT;

ADIPOCYTE; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLEPTINEMIA; IN VITRO STUDY; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; METABOLIC DISORDER; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; OBESITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RECEPTOR UPREGULATION; BIOSYNTHESIS; CELL CULTURE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; HYPERINSULINISM; MALE; METABOLISM; MONONUCLEAR CELL; DRUG EFFECT;

ADULT; ANTI-INFLAMMATORY AGENTS; ATHEROSCLEROSIS; CELLS, CULTURED; CYTOKINES; DEXAMETHASONE; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; HYPOGLYCEMIC AGENTS; INFLAMMATION MEDIATORS; INSULIN; LEPTIN; LEUKOCYTES, MONONUCLEAR; MALE; OBESITY; RESISTIN; RNA, MESSENGER; SWEETENING AGENTS;

EID: 84874585039     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/487081     Document Type: Article

References (51)

1. Fasshauer M., Paschke R., Regulation of adipocytokines and insulin resistance. Diabetologia 2003 46 12 1594 1603 2-s2.0-0348107406 10.1007/s00125-003-1228-z (Pubitemid 38005321)
2. Murdolo G., Smith U., The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis. Nutrition, Metabolism & Cardiovascular Diseases 2006 16 supplement 1 S35 S38 2-s2.0-33645452759 10.1016/j.numecd.2005.10.016
3. Bouloumié A., Curat C. A., Sengenès C., Lolmède K., Miranville A., Busse R., Role of macrophage tissue infiltration in metabolic diseases. Current Opinion in Clinical Nutrition and Metabolic Care 2005 8 4 347 354 2-s2.0-20844460279 (Pubitemid 40863045)
4. Steppan C. M., Bailey S. T., Bhat S., Brown E. J., Banerjee R. R., Wright C. M., Patel H. R., Ahima R. S., Lazar M. A., The hormone resistin links obesity to diabetes. Nature 2001 409 6818 307 312 2-s2.0-0035905758 10.1038/35053000 (Pubitemid 32151228)
5. Rajala M. W., Obici S., Scherer P. E., Rossetti L., Adipose-derived resistin and gut-derived resistin-like molecule- β selectively impair insulin action on glucose production. The Journal of Clinical Investigation 2003 111 2 225 230 2-s2.0-0037241112 10.1172/JCI200316521 (Pubitemid 36105921)
6. Rangwala S. M., Rich A. S., Rhoades B., Shapiro J. S., Obici S., Rossetti L., Lazar M. A., Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes 2004 53 8 1937 1941 2-s2.0-3242806013 10.2337/diabetes.53.8.1937 (Pubitemid 38970738)
7. Muse E. D., Obici S., Bhanot S., Monia B. P., McKay R. A., Rajala M. W., Scherer P. E., Rossetti L., Role of resistin in diet-induced hepatic insulin resistance. The Journal of Clinical Investigation 2004 114 2 232 239 2-s2.0-4043082182 10.1172/JCI200421270 (Pubitemid 39071628)
8. Tsiotra P. C., Tsigos C., Anastasiou E., Yfanti E., Boutati E., Souvatzoglou E., Kyrou I., Raptis S. A., Peripheral mononuclear cell resistin mRNA expression is increased in type 2 diabetic women. Mediators of Inflammation 2008 2008 2-s2.0-58149461380 10.1155/2008/892864 892864
9. Degawa-Yamauchi M., Bovenkerk J. E., Juliar B. E., Watson W., Kerr K., Jones R., Zhu Q., Considine R. V., Serum resistin (FIZZ3) protein is increased in obese humans. Journal of Clinical Endocrinology and Metabolism 2003 88 11 5452 5455 2-s2.0-0344874247 10.1210/jc.2002-021808 (Pubitemid 37452753)
10. Vozarova de Courten B., Degawa-Yamauchi M., Considine R. V., Tataranni P. A., High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes 2004 53 1279 1284 (Pubitemid 38569014)
11. Lee J. H., Chan J. L., Yiannakouris N., Kontogianni M., Estrada E., Seip R., Orlova C., Mantzoros C. S., Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. Journal of Clinical Endocrinology and Metabolism 2003 88 10 4848 4856 2-s2.0-0242320395 10.1210/jc.2003-030519 (Pubitemid 37357535)
12. Utzschneider K. M., Carr D. B., Tong J., Wallace T. M., Hull R. L., Zraika S., Xiao Q., Mistry J. S., Retzlaff B. M., Knopp R. H., Kahn S. E., Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia 2005 48 11 2330 2333 2-s2.0-27744545199 10.1007/s00125-005-1932-y (Pubitemid 41618925)
13. Savage D. B., Sewter C. P., Klenk E. S., Segal D. G., Vidal-Puig A., Considine R. V., O'Rahilly S., Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor- γ action in humans. Diabetes 2001 50 10 2199 2202 2-s2.0-0035487109 (Pubitemid 33641901)
14. Patel L., Buckels A. C., Kinghorn I. J., Murdock P. R., Holbrook J. D., Plumpton C., Macphee C. H., Smith S. A., Resistin is expressed in human macrophages and directly regulated by PPAR γ activators. Biochemical and Biophysical Research Communications 2003 300 2 472 476 2-s2.0-0037427540 10.1016/S0006-291X(02)02841-3 (Pubitemid 38375833)
15. Silswal N., Singh A. K., Aruna B., Mukhopadhyay S., Ghosh S., Ehtesham N. Z., Human resistin stimulates the pro-inflammatory cytokines TNF- α and IL-12 in macrophages by NF- B-dependent pathway. Biochemical and Biophysical Research Communications 2005 334 4 1092 1101 2-s2.0-23044439100 10.1016/j.bbrc.2005.06.202 (Pubitemid 41074686)
16. Bokarewa M., Nagaev I., Dahlberg L., Smith U., Tarkowski A., Resistin, an adipokine with potent proinflammatory properties. The Journal of Immunology 2005 174 9 5789 5795 2-s2.0-17844392652 (Pubitemid 40593223)
17. Lehrke M., Reilly M. P., Millington S. C., Iqbal N., Rader D. J., Lazar M. A., An inflammatory cascade leading to hyperresistinemia in humans. PLoS Medicine 2004 1 161 168 2-s2.0-15744399190 10.1371/journal.pmed.0010045 (Pubitemid 40412718)
18. Stejskal D., Adamovská S., Bartek J., Juráková R., Prosková J., Resistin-concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomedical Papers 2003 147 1 63 69 2-s2.0-58149232603
19. Verma S., Li S. H., Wang C. H., Fedak P. W. M., Li R. K., Weisel R. D., Mickle D. A. G., Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003 108 6 736 740 2-s2.0-0043164953 10.1161/01.CIR.0000084503.91330.49 (Pubitemid 36999260)
20. Kawanami D., Maemura K., Takeda N., Harada T., Nojiri T., Imai Y., Manabe I., Utsunomiya K., Nagai R., Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochemical and Biophysical Research Communications 2004 314 2 415 419 2-s2.0-0347004641 10.1016/j.bbrc.2003.12.104 (Pubitemid 38084733)
21. Jung H. S., Park K. H., Cho Y. M., Chung S. S., Cho H. J., Cho S. Y., Kim S. J., Kim S. Y., Lee H. K., Park K. S., Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovascular Research 2006 69 1 76 85 2-s2.0-29144432822 10.1016/j.cardiores.2005.09.015 (Pubitemid 41814813)
22. Burnett M. S., Devaney J. M., Adenika R. J., Lindsay R., Howard B. V., Cross-sectional associations of resistin, coronary heart disease, and insulin resistance. Journal of Clinical Endocrinology and Metabolism 2006 91 1 64 68 2-s2.0-30344453371 10.1210/jc.2005-1653 (Pubitemid 43069119)
23. Reilly M. P., Lehrke M., Wolfe M. L., Rohatgi A., Lazar M. A., Rader D. J., Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005 111 7 932 939 2-s2.0-14044257211 10.1161/01.CIR.0000155620.10387.43 (Pubitemid 40279897)
24. Frankel D. S., Vasan R. S., D'Agostino R. B., Benjamin E. J., Levy D., Wang T. J., Meigs J. B., Resistin, adiponectin, and risk of heart failure. The Framingham offspring study. Journal of the American College of Cardiology 2009 53 9 754 762 2-s2.0-60449091233 10.1016/j.jacc.2008.07.073
25. Prescott S. M., Zimmerman G. A., McIntyre T. M., Stafforini D. M., Inflammation in the vascular wall as an early event in atherosclerosis. Diabetologia 1997 40 2, supplement S111 S112 2-s2.0-0030789556 10.1007/s001250051420 (Pubitemid 27306933)
26. Tsigos C., Kyrou I., Chala E., Tsapogas P., Stavridis J. C., Raptis S. A., Katsilambros N., Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism 1999 48 10 1332 1335 2-s2.0-0032743517 10.1016/S0026-0495(99)90277-9 (Pubitemid 29496085)
27. Ridker P. M., Rifai N., Pfeffer M., Sacks F., Lepage S., Braunwald E., Elevation of tumor necrosis factor- α and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000 101 18 2149 2153 2-s2.0-0034625079 (Pubitemid 30253042)
28. Ridker P. M., Rifai N., Stampfer M. J., Hennekens C. H., Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000 101 15 1767 1772 2-s2.0-0034681920 (Pubitemid 30213096)
29. Spranger J., Kroke A., Möhlig M., Hoffmann K., Bergmann M. M., Ristow M., Boeing H., Pfeiffer A. F. H., Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-potsdam study. Diabetes 2003 52 3 812 817 2-s2.0-0345700727 10.2337/diabetes.52.3.812 (Pubitemid 36323590)
30. Tsiotra P. C., Pappa V., Raptis S. A., Tsigos C., Expression of the long and short leptin receptor isoforms in peripheral blood mononuclear cells: implications for leptin's actions. Metabolism 2000 49 12 1537 1541 2-s2.0-0034534905 10.1053/meta.2000.18519 (Pubitemid 32010839)
31. Tsiotra P. C., Tsigos C., Yfanti E., Anastasiou E., Vikentiou M., Psarra K., Papasteriades C., Raptis S. A., Visfatin, TNF- α and IL-6 mRNA expression is increased in mononuclear cells from type 2 diabetic women. Hormone and Metabolic Research 2007 39 10 758 763 2-s2.0-36149000997 10.1055/s-2007-990288 (Pubitemid 350103437)
32. Shojima N., Sakoda H., Ogihara T., Fujishiro M., Katagiri H., Anai M., Onishi Y., Ono H., Inukai K., Abe M., Fukushima Y., Kikuchi M., Oka Y., Asano T., Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells. Diabetes 2002 51 6 1737 1744 2-s2.0-0036267020 (Pubitemid 34564285)
33. Stan D., Calin M., Manduteanu I., Pirvulescu M., Gan A. M., Butoi E. D., Simion V., Simionescu M., High glucose induces enhanced expression of resistin in human U937 monocyte-like cell line by MAPK- and NF-kB-dependent mechanisms; the modulating effect of insulin. Cell and Tissue Research 2011 343 2 379 387 2-s2.0-79953874256 10.1007/s00441-010-1092-3
34. Kawashima J., Tsuruzoe K., Motoshima H., Shirakami A., Sakai K., Hirashima Y., Toyonaga T., Araki E., Insulin down-regulates resistin mRNA through the synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes. Diabetologia 2003 46 2 231 240 2-s2.0-0037299942 (Pubitemid 36343887)
35. Kim K. H., Lee K., Moon Y. S., Sul H. S., A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. The Journal of Biological Chemistry 2001 276 14 11252 11256 2-s2.0-0035815608 10.1074/jbc.C100028200 (Pubitemid 38089312)
36. McTernan P. G., Fisher F. M., Valsamakis G., Chetty R., Harte A., McTernan C. L., Clark P. M. S., Smith S. A., Barnett A. H., Kumar S., Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. Journal of Clinical Endocrinology and Metabolism 2003 88 12 6098 6106 2-s2.0-9144244927 10.1210/jc.2003-030898 (Pubitemid 38033098)
37. Zhang J., Zhou L., Tang L., The plasma level and gene expression of resistin in polycystic ovary syndrome. Gynecological Endocrinology 2011 27 12 982 987 10.3109/09513590.2011.569794
38. Kaser S., Kaser A., Sandhofer A., Ebenbichler C. F., Tilg H., Patsch J. R., Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochemical and Biophysical Research Communications 2003 309 2 286 290 2-s2.0-0042925580 10.1016/j.bbrc.2003.07.003 (Pubitemid 37025889)
39. Asensio C., Cettour-Rose P., Theander-Carrillo C., Rohner-Jeanrenaud F., Muzzin P., Changes in glycemia by leptin administration or high-fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis. Endocrinology 2004 145 5 2206 2213 2-s2.0-2042438401 10.1210/en.2003-1679 (Pubitemid 38535049)
40. Yang R. Z., Huang Q., Xu A., McLenithan J. C., Eison J. A., Shuldiner A. R., Alkan S., Gong D. W., Comparative studies of resistin expression and phylogenomics in human and mouse. Biochemical and Biophysical Research Communications 2003 310 3 927 935 2-s2.0-0141868801 10.1016/j.bbrc.2003.09.093 (Pubitemid 37188711)
41. Ghosh S., Singh A. K., Aruna B., Mukhopadhyay S., Ehtesham N. Z., The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications. Gene 2003 305 1 27 34 2-s2.0-0037434632 10.1016/S0378-1119(02)01213-1 (Pubitemid 36197863)
42. Hâncu N., Netea M. G., Baciu I., High glucose concentrations increase the tumor necrosis factor-alpha production capacity by human peripheral blood mononuclear cells. Romanian Journal of Physiology 1998 35 3-4 325 330 2-s2.0-0032106026
43. Iida K. T., Shimano H., Kawakami Y., Sone H., Toyoshima H., Suzuki S., Asano T., Okuda Y., Yamada N., Insulin up-regulates tumor necrosis factor- α production in macrophages through an extracellular-regulated kinase-dependent pathway. The Journal of Biological Chemistry 2001 276 35 32531 32537 2-s2.0-0035980021 10.1074/jbc.M009894200
44. Bessler H., Mendel C., Straussberg R., Gurary N., Aloni D., Sirota L., Effects of dexamethasone on IL-1 β IL-6, and TNF- α production by mononuclear cells of newborns and adults. Biology of the Neonate 1999 75 4 225 233 2-s2.0-0033060103 (Pubitemid 29112509)
45. Stienstra R., van Diepen J. A., Tack C. J., Inflammasome is a central player in the induction of obesity and insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 2011 108 37 15324 15329 10.1073/pnas.1100255108
46. Xu H., Barnes G. T., Yang Q., Chronic inflammation in fat plays a crusial role in the development of obesity-related insulin resistance. The Journal of Clinical Investigation 2003 112 12 1821 1830 (Pubitemid 38063705)
47. Cho Y., Lee S. E., Lee H. C., Hur J., Lee S., Youn S. W., Lee J., Lee H. J., Lee T. K., Park J., Hwang S. J., Kwon Y. W., Cho H. J., Oh B. H., Park Y. B., Kim H. S., Adipokine resistin is a key player to modulate monocytes, endothelial cells, and smooth muscle cells, leading to progression of atherosclerosis in rabbit carotid artery. Journal of the American College of Cardiology 2010 57 1 99 109 2-s2.0-78650536956 10.1016/j.jacc.2010.07.035
48. Ohmori R., Momiyama Y., Kato R., Taniguchi H., Ogura M., Ayaori M., Nakamura H., Ohsuzu F., Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. Journal of the American College of Cardiology 2005 46 2 379 380 2-s2.0-22044437691 10.1016/j.jacc.2005. 04.022 (Pubitemid 40966873)
49. Burnett M. S., Lee C. W., Kinnaird T. D., Stabile E., Durrani S., Dullum M. K., Devaney J. M., Fishman C., Stamou S., Canos D., Zbinden S., Clavijo L. C., Jang G. J., Andrews J. A., Zhu J., Epstein S. E., The potential role of resistin in atherogenesis. Atherosclerosis 2005 182 2 241 248 2-s2.0-24644479276 10.1016/j.atherosclerosis.2005.02.014 (Pubitemid 41267191)
50. Rae C., Graham A., Human resistin promotes macrophage lipid accumulation. Diabetologia 2006 49 5 1112 1114 2-s2.0-33646390976 10.1007/s00125-006-0187-6
51. Pang S. S., Le Y. Y., Role of resistin in inflammation and inflammation-related diseases. Cellular & Molecular Immunology 2006 3 1 29 34 2-s2.0-33745171469